EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Compound 17 Inhibits Lung Cancer Progression via Inducing Cellular Apoptosis and Blocking TNF Signaling Pathway Activation

Jiexin Zhang, Yunya Zhang, Yaru Zhao, Huiyue Shen, Yan Zhao iD, Hongbo Teng

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27041693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jiexin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Apoptosis, Signal Transduction, Tumor Necrosis Factor-alpha. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningxia Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer ranks among the most commonly diagnosed malignancies worldwide, with dismal prognosis largely due to its intrinsic drug resistance and high recurrence rate. Herein, we synthesized 30 glycyrrhetinic acid derivatives and evaluated their anti-lung cancer potential both in vitro and in vivo. The biological effects of compound 17 on A549 cells were determined using MTT, colony formation, and Transwell assays. Flow cytometry, transcriptomic profiling, and RT-qPCR were performed to identify differentially expressed genes, followed by GO and KEGG enrichment analyses and molecular docking validation. A mouse xenograft tumor model was employed to assess therapeutic efficacy and systemic toxicity. Compound 17 exhibited dose-dependent inhibition of A549 cell proliferation, migration, and invasion, achieving an IC50 value of 0.6011 ± 0.05 μM. It induced G1-phase cell cycle arrest and apoptosis by inhibiting the TNF signaling pathway and modulating apoptosis-related proteins. In vivo experiments demonstrated that compound 17 exerted a tumor inhibition rate of 80.61% without observable toxic side effects. This study is the first to demonstrate that compound 17 exerts potent anti-lung cancer activity by targeting the TNF signaling pathway and activating the mitochondrial apoptosis pathway, providing a critical experimental foundation for its development as a novel therapeutic agent against lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsApoptosisSignal TransductionTumor Necrosis Factor-alphaGlycyrrhetinic AcidAntineoplastic AgentsHumansAnimalsMiceCell ProliferationA549 CellsXenograft Model Antitumor AssaysCell MovementMolecular Docking SimulationMice, NudeGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

TNFapoptosisglycyrrhetinic acid derivativeslung cancerstructural modification

Substanzen

Tumor Necrosis Factor-alphaGlycyrrhetinic AcidAntineoplastic Agents

Autor:innen und Institutionen

  • College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
  • International Joint Laboratory for Development of Animal and Plant Resources for Food and Medicine, Jilin Agricultural University, Changchun 130118, China.

ORCID-Profile: Yan Zhao

Förderung

  • Ningxia Natural Science Foundation Project

Zitieren

APA

Zhang, J., Zhang, Y., Zhao, Y., Shen, H., Zhao, Y., & Teng, H. (2026). Compound 17 Inhibits Lung Cancer Progression via Inducing Cellular Apoptosis and Blocking TNF Signaling Pathway Activation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041693

Vancouver

Zhang J, Zhang Y, Zhao Y, Shen H, Zhao Y, Teng H. Compound 17 Inhibits Lung Cancer Progression via Inducing Cellular Apoptosis and Blocking TNF Signaling Pathway Activation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041693

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiexin and Zhang, Yunya and Zhao, Yaru and Shen, Huiyue and Zhao, Yan and Teng, Hongbo},
  title = {Compound 17 Inhibits Lung Cancer Progression via Inducing Cellular Apoptosis and Blocking TNF Signaling Pathway Activation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27041693}
}
Kostenlos starten →